prednisolone has been researched along with Atypical Lipomatous Tumor in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogihara, T | 1 |
| Inagaki, Y | 1 |
| Nagata, S | 1 |
| Kiryu, Y | 1 |
| Miyake, S | 1 |
| Shimizu, K | 1 |
1 other study available for prednisolone and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Combination chemotherapy in retroperitoneal poorly differentiated myxoid liposarcoma: a report of a case.
Topics: Antineoplastic Agents; Constriction, Pathologic; Cyclophosphamide; Dactinomycin; Diabetes Mellitus; | 1983 |